German China India

Portugal: Pharmaceuticals

Fresenius Kabi Starts Operation of New Production Line in Portugal

| Editor: Alexander Stark

Representing the national government at the opening ceremony were special guests Manuel Delgado, Secretary of State of Health, and João Vasconcelos, Secretary of State of Industry.
Representing the national government at the opening ceremony were special guests Manuel Delgado, Secretary of State of Health, and João Vasconcelos, Secretary of State of Industry. (Source: Fresenius Kabi)

Fresenius Kabi has put two new production lines for antibiotics into operation at its plant in Santiago de Besteiros, Portugal.

Bad Homburg/Germany — A new 6,000 m2 building was erected to house the two lines, which will be used to produce penicillin for intravenous administration. About 80 new jobs are being created at the Santiago de Besteiros plant by the expansion, the company says. The total investment is about € 17 million.

Dr. Michael Schönhofen, member of the Fresenius Kabi Management Board and President of the Pharmaceuticals Division, said: “This expansion is a clear commitment to our Santiago de Besteiros facility, and to Portugal. It is also a part of fulfilling our promise to provide patients worldwide with high-quality drugs.”

The Fresenius Kabi plant in Santiago de Besteiros manufactures various pharmaceuticals, such as antibiotics and infusion solutions. The site employs about 600 people.

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 44782152 / Pharma & Food)